down arrow

Orexo AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0000736415
SEK
24.70
-1.25 (-4.82%)

Dec 04

OME

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Cantargia AB
Oncopeptides AB
Xbrane Biopharma AB
Egetis Therapeutics AB
Orexo AB
Cereno Scientific AB
Xspray Pharma AB
Diamyd Medical AB
Infant Bacterial Therapeutics AB
SynAct Pharma AB
FluoGuide A/S
Why is Orexo AB ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Net Sales has grown by an annual rate of -6.05% and Operating profit at -218.27% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2
The company has declared Negative results for the last 3 consecutive quarters
  • NET PROFIT(HY) At SEK -55.7 MM has Grown at -24.33%
  • CASH AND EQV(HY) Lowest at SEK 240.4 MM
  • NET SALES(Q) Lowest at SEK 118.2 MM
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 70.34%, its profits have fallen by -121.1%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Orexo AB for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Orexo AB
70.34%
0.19
64.85%
OMX Stockholm 30
8.01%
0.44
18.11%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-6.05%
EBIT Growth (5y)
-218.27%
EBIT to Interest (avg)
-5.40
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.24
Sales to Capital Employed (avg)
1.45
Tax Ratio
4.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-6.70
EV to EBIT
-10.15
EV to EBITDA
456.81
EV to Capital Employed
9.70
EV to Sales
3.01
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-95.64%
ROE (Latest)
Negative BV
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
OPERATING CASH FLOW(Y)

Highest at SEK 24.9 MM

NET PROFIT(HY)

Higher at SEK -55.7 MM

RAW MATERIAL COST(Y)

Fallen by -9.8% (YoY

-12What is not working for the Company
NET PROFIT(HY)

At SEK -55.7 MM has Grown at -24.33%

CASH AND EQV(HY)

Lowest at SEK 240.4 MM

NET SALES(Q)

Lowest at SEK 118.2 MM

OPERATING PROFIT(Q)

Lowest at SEK -7.1 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -6.01 %

Here's what is working for Orexo AB
Operating Cash Flow
Highest at SEK 24.9 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Net Profit
Higher at SEK -55.7 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (SEK MM)

Raw Material Cost
Fallen by -9.8% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Orexo AB
Net Sales
At SEK 118.2 MM has Fallen at -20.8%
over average net sales of the previous four periods of SEK 149.25 MM
MOJO Watch
Near term sales trend is very negative

Net Sales (SEK MM)

Net Profit
At SEK -55.7 MM has Grown at -24.33%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (SEK MM)

Net Sales
Lowest at SEK 118.2 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (SEK MM)

Operating Profit
Lowest at SEK -7.1 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (SEK MM)

Operating Profit Margin
Lowest at -6.01 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Cash and Eqv
Lowest at SEK 240.4 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."